The UK DNA Banking Network
Lead Research Organisation:
University of Manchester
Department Name: Medical and Human Sciences
Abstract
The UK DNA Banking Network (UDBN at www.dna-network.ac.uk) manages data and sample collections for common human diseases. High quality management is essential for genetic epidemiology. It saves time and money; allows UK scientists access to these valuable resources; and allows the gathering together of the large series that are now essential to find genes underlying common diseases. Already six of the collections have been used in this way with >6 billion genetic variants tested in >12,000 samples. Round the world, genetic epidemiologists are trying to tackle the huge logistic problems associated with these numbers. UDBN has solved most of them. No other nation has yet got this sort of infrastructure. We now plan to speed up the process of making collections for more diseases so that more genes will be found quicker and cheaper. We want to see UDBN serve the needs of all collectors - not only those funded by MRC. We also want to ensure that the management we provide remains at the cutting edge of robotics and informatics. Our current collections are in Coronary Artery Disease; Colorectal cancer; Glomerulonephritis; Parkinson‘s Disease; Asthma; Eczema; Type 2 Diabetes; Breast Cancer; Hypertension; Multiple Sclerosis; Alzheimer‘s Disease; Macular Degeneration; Unipolar Depression.
Technical Summary
A national community resource has been created for DNA sample and data management to support UK scientists investigating genetic risk factors in 13 high impact diseases. The resource - the UK DNA Banking Network - comprises ISO 2001 facilities in CIGMR (Manchester) and ECACC (Salisbury) for managing DNA and cell samples respectively. The facilities make extensive use of robotics supported by LIMS. The Network has a highly functional website that provides a ?Collaboration Service? akin to a dating agency for collaboration. This service involves linking of CIGMR and ECACC LIMS with collectors? phenotype databases. UDBN collections are being analysed in high density genome wide association and other studies. This community resource is the most advanced of its kind.
UDBN seeks renewed support to retain this world-leading position. Support will allow us to promote wider use of the samples; to sustain the Network; to maintain its infrastructure; to complete the data management infrastructure; to roll out the management capabilities for other human disease collections (including clinical trials); massively to save costs to all funding bodies planning to support new collections; to adapt UDBN?s organisation as links to other funders grow; to test revenue streams for UDBN that will ensure cost-effective use of resources and to implement a programme of research and development. This programme will achieve wider harmonisation of DNA sample management processes; will conserve irreplaceable genomic DNA samples; will facilitate DNA sample accrual from rarer diseases or sub-types (from wax blocks); and will facilitate accrual of further sub-cellular fractions (RNA) for high throughput analysis.
UDBN seeks renewed support to retain this world-leading position. Support will allow us to promote wider use of the samples; to sustain the Network; to maintain its infrastructure; to complete the data management infrastructure; to roll out the management capabilities for other human disease collections (including clinical trials); massively to save costs to all funding bodies planning to support new collections; to adapt UDBN?s organisation as links to other funders grow; to test revenue streams for UDBN that will ensure cost-effective use of resources and to implement a programme of research and development. This programme will achieve wider harmonisation of DNA sample management processes; will conserve irreplaceable genomic DNA samples; will facilitate DNA sample accrual from rarer diseases or sub-types (from wax blocks); and will facilitate accrual of further sub-cellular fractions (RNA) for high throughput analysis.
Organisations
- University of Manchester, Manchester, United Kingdom (Lead Research Organisation)
- Government of France (Collaboration)
- UK Biobank, United Kingdom (Collaboration)
- Karolinska University Hospital (Collaboration)
- Federal Ministry of Science, Research and Economy (BMWFW) (Collaboration)
- London School of Economics & Pol Sci, United Kingdom (Collaboration)
- Boehringer Ingelheim, Germany (Collaboration)
- Helmholtz Association of German Research Centres (Collaboration)
- King's College Hospital Charitable Trust, United Kingdom (Collaboration)
- Almirall (Collaboration)
- AstraZeneca plc (Collaboration)
- Lundbeck Foundation (Collaboration)
- Norwegian Institute of Public Health (Collaboration)
- deCODE Genetics (Collaboration)
- National Institute for Cancer Research, Genoa (IST) (Istituto Nazionale per la Ricerca sul Cancro di Genova) (Collaboration)
- Leiden University Medical Center (Collaboration)
- Academy of Athens (Collaboration)
- University of Oxford, United Kingdom (Collaboration)
- Norwegian University of Science and Technology (NTNU) (Collaboration)
- Max Planck Society (Collaboration)
- University of Klagenfurt (Collaboration)
- Government of the Netherlands (Collaboration)
- National Research Council CNR - Italy (Collaboration)
- UCB Pharma, Belgium (Collaboration)
- GlaxoSmithKline (GSK) (Collaboration)
- University of Vienna (Collaboration)
- Molecular Medicine Ireland (Collaboration)
- University of Tartu, Estonia (Collaboration)
- Pfizer Ltd (Collaboration)
- International Agency for Research on Cancer (IARC) (Collaboration)
- German Federal Ministry of Education and Research (Collaboration)
- Medical University of Graz, Austria (Collaboration)
- Babraham Bioscience Technologies (Collaboration)
- National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS) (Collaboration)
- Erasmus MC (Collaboration)
- Government of Estonia (Collaboration)
- EMBL - European Bioinformatics Institute, United Kingdom (Collaboration)
- Fraunhofer Society (Collaboration)
- Telethon Foundation (Collaboration)
- National Institute of Health (Collaboration)
- General Secretariat For Research & Technology (Collaboration)
- The Icelandic Centre for Research (Collaboration)
- University of Salamanca, Spain (Collaboration)
- Alliance Against Cancer (Collaboration)
- Academic Medical Center (Collaboration)
- Netherlands Organisation for Health Research and Development (Collaboration)
- Johnson & Johnson Ltd, United Kingdom (Collaboration)
- Novartis (Collaboration)
- National Institute of Health and Medical Research (INSERM) (Collaboration)
- F. Hoffmann-La Roche AG (Collaboration)
- Sanofi (Collaboration)
- Bayer (Collaboration)
- Esteve (Collaboration)
- Uppsala University (Collaboration)
- Karolinska Institute, Sweden (Collaboration)
- Medical Research Council (Collaboration)
- Vitro (Biobanking services) (Collaboration)
- Autonomous University of Madrid, Spain (Collaboration)
- Health Research Board (HRB) (Collaboration)
- Medical University of Vienna (Collaboration)
- Netherlands Federation of University Medical Centres (NFU) (Collaboration)
- Orion Corporation (Collaboration)
- University Medical Center Gronigen (Collaboration)
- University of Malta (Collaboration)
- Semmelweis University (Collaboration)
- Novo Nordisk (Collaboration)
- Legal Pathways Institute for Health and Bio-Law (Collaboration)
- Spanish Ministry of Science and Innovation (Collaboration)
Publications
Ehret GB
(2013)
Genes for blood pressure: an opportunity to understand hypertension.
in European heart journal
Elliott KS
(2013)
Evaluation of the genetic overlap between osteoarthritis with body mass index and height using genome-wide association scan data.
in Annals of the rheumatic diseases
Fox-Clipsham LY
(2011)
Identification of a mutation associated with fatal Foal Immunodeficiency Syndrome in the Fell and Dales pony.
in PLoS genetics
Ganesh SK
(2013)
Loci influencing blood pressure identified using a cardiovascular gene-centric array.
in Human molecular genetics
Ghosh SM
(2013)
Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential.
in Hypertension (Dallas, Tex. : 1979)
Guerin JS
(2010)
Molecular medicine ireland guidelines for standardized biobanking.
in Biopreservation and biobanking
Gusareva ES
(2016)
Corrigendum to "Genome-wide association interaction analysis for Alzheimer's disease." [Neurobiol. Aging 35 (2014) 2436-2443].
in Neurobiology of aging
Gusareva ES
(2018)
Male-specific epistasis between WWC1 and TLN2 genes is associated with Alzheimer's disease.
in Neurobiology of aging
Hackinger S
(2017)
Evaluation of shared genetic aetiology between osteoarthritis and bone mineral density identifies SMAD3 as a novel osteoarthritis risk locus.
in Human molecular genetics
Hamilton G
(2012)
The role of ECE1 variants in cognitive ability in old age and Alzheimer's disease risk.
in American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
| Description | Confederation of Cancer Biobanking |
| Geographic Reach | National |
| Policy Influence Type | Participation in advisory committee |
| Impact | no |
| Description | GeneLibrary Ireland |
| Geographic Reach | Europe |
| Policy Influence Type | Participation in advisory committee |
| Impact | None |
| Description | FP7-INFRASTRUCTURES-2007-1 |
| Amount | £150,000 (GBP) |
| Organisation | European Commission |
| Department | Seventh Framework Programme (FP7) |
| Sector | Public |
| Country | European Union (EU) |
| Start | 02/2007 |
| End | 01/2011 |
| Description | Innovative Medicines Initiative (IMI) Call 1 Topic 14 |
| Amount | £350,000 (GBP) |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 10/2009 |
| End | 09/2017 |
| Description | Manchester Academic Health Science Centre Pilot Funding/University of Manchester |
| Amount | £40,000 (GBP) |
| Organisation | University of Manchester |
| Department | Manchester Academic Health Science Centre |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 08/2009 |
| End | 07/2011 |
| Title | CoMS |
| Description | This Collaboration Management System permits the initiation of collaborations between resource owners in UDBN and third parties. |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2007 |
| Provided To Others? | Yes |
| Impact | UDBN has distributed 80,000 aliquots to researchers involved in different collaborative arrangements. |
| Title | PRELIMS |
| Description | Permits centralised web-based project management of collection activities (track sample; track consent; phenotype data entry). |
| Type Of Material | Improvements to research infrastructure |
| Provided To Others? | No |
| Impact | Too early to say |
| Description | Acropolis |
| Organisation | King's College Hospital NHS Foundation Trust (NCH) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Management of data integration project for research between MAHSC and KHP |
| Impact | Too soon |
| Start Year | 2011 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Academy of Athens |
| Department | Biomedical Research Foundation Academy of Athens |
| Country | Greece |
| Sector | Charity/Non Profit |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Alliance Against Cancer |
| Country | Italy |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Autonomous University of Madrid |
| Country | Spain |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Babraham Bioscience Technologies |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | EMBL European Bioinformatics Institute (EMBL - EBI) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Erasmus MC |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Federal Ministry of Science, Research and Economy (BMWFW) |
| Country | Austria |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Fraunhofer Society |
| Department | The Fraunhofer Institute for Biomedical Engineering (IBMT) |
| Country | Germany |
| Sector | Private |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | General Secretariat For Research & Technology |
| Country | Greece |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | German Federal Ministry of Education and Research |
| Country | Germany |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Government of Estonia |
| Department | Ministry of Education and Research Estonia |
| Country | Estonia |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Government of France |
| Department | Fédération Hospitalière de France (FHF) |
| Country | France |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Government of the Netherlands |
| Department | Ministry of Education, Culture and Science Netherlands |
| Country | Netherlands |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Health Research Board (HRB) |
| Country | Ireland |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Helmholtz Association of German Research Centres |
| Department | Helmholtz Zentrum Munchen |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Helmholtz Association of German Research Centres |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | International Agency for Research on Cancer (IARC) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Legal Pathways Institute for Health and Bio-Law |
| Country | Netherlands |
| Sector | Private |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Leiden University Medical Center |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | London School of Economics and Political Science (University of London) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Max Planck Society |
| Department | Max Planck Institute for Molecular Cell Biology and Genetics |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Medical Research Council (MRC) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Medical University of Graz |
| Country | Austria |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Molecular Medicine Ireland |
| Department | Irish Clinical Research Infrastructure Network (ICRIN) |
| Country | Ireland |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | National Institute for Cancer Research, Genoa (IST) (Istituto Nazionale per la Ricerca sul Cancro di Genova) |
| Country | Italy |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | National Institute of Health |
| Country | Italy |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | National Institute of Health and Medical Research (INSERM) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | National Research Council |
| Department | ITB CNR Institute for Biomedical Technologies |
| Country | Italy |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Netherlands Federation of University Medical Centres (NFU) |
| Country | Netherlands |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Netherlands Organisation for Health Research and Development |
| Country | Netherlands |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Norwegian Institute of Public Health |
| Country | Norway |
| Sector | Public |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Norwegian University of Science and Technology (NTNU) |
| Country | Norway |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Semmelweiss University |
| Country | Hungary |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Spanish Ministry of Science and Innovation |
| Department | Institute of Health "Carlos III" (ISCIII) |
| Country | Spain |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Telethon Foundation |
| Country | Italy |
| Sector | Charity/Non Profit |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | The Icelandic Centre for Research |
| Country | Iceland |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | UK Biobank |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | University Medical Center Gronigen |
| Country | Netherlands |
| Sector | Hospitals |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | University of Klagenfurt |
| Country | Austria |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | University of Malta |
| Country | Malta |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | University of Salamanca |
| Country | Spain |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | University of Tartu |
| Country | Estonia |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | University of Vienna |
| Department | Life Science Governance Institute, Vienna |
| Country | Austria |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Uppsala University |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | Vitro (Biobanking services) |
| Country | Spain |
| Sector | Private |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | Biobanking and BioMolecular Resources Infrastructure |
| Organisation | deCODE genetics |
| Country | Iceland |
| Sector | Academic/University |
| PI Contribution | I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted €150,000 from FP7-Research Infrastructures. |
| Collaborator Contribution | Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN |
| Impact | Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap. |
| Start Year | 2008 |
| Description | IMI EMTRAIN |
| Organisation | Almirall |
| Country | Spain |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | AstraZeneca |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Bayer |
| Country | Germany |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Boehringer Ingelheim |
| Country | Germany |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | EMBL European Bioinformatics Institute (EMBL - EBI) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Esteve |
| Country | Spain |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | F. Hoffmann-La Roche AG |
| Country | Global |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | GlaxoSmithKline (GSK) |
| Country | Global |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Helmholtz Association of German Research Centres |
| Department | Helmholtz Centre for Infection Research (HZI) |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Helmholtz Association of German Research Centres |
| Department | Helmholtz Zentrum Munchen |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Johnson & Johnson |
| Country | United States |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Karolinska Institute |
| Department | Division of Metabolic Diseases |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Karolinska University Hospital |
| Country | Sweden |
| Sector | Hospitals |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Lundbeck Foundation |
| Country | Denmark |
| Sector | Charity/Non Profit |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Medical University of Graz |
| Country | Austria |
| Sector | Academic/University |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Medical University of Vienna |
| Country | Austria |
| Sector | Academic/University |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | National Institute of Health and Medical Research (INSERM) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Novartis |
| Country | Global |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Novo Nordisk |
| Country | Denmark |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Orion Corporation |
| Department | ORION Pharma |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Pfizer Ltd |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Sanofi |
| Department | Aventis |
| Country | France |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | Sanofi |
| Department | Genzyme Corporation |
| Country | United States |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | UCB Pharma |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI EMTRAIN |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision. |
| Collaborator Contribution | Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking |
| Impact | www.emtrain.eu |
| Start Year | 2009 |
| Description | IMI U-biopred |
| Organisation | Academic Medical Center |
| Department | Department of Respiratory Medicine |
| Country | Netherlands |
| Sector | Hospitals |
| PI Contribution | Biobanking infrastructure |
| Impact | Too soon |
| Start Year | 2010 |
| Description | Stratum |
| Organisation | AstraZeneca |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Financial modelling for national biobanking solutions |
| Impact | Too soon |
| Start Year | 2011 |
| Description | Local news item on brain donation for dementia research |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Public/other audiences |
| Results and Impact | Older people in Wales are being urged to think about donating their brains after they die to help scientists researching dementia. This has sparked questions and debates - 80 comments within 24 hours. It will definitely influence people by raising awareness of the disease, the process of donation, benefits of donation/research and also opting in/out law change. We are confident this will increase the number of healthy/diseased donations and positively impact research field. |
| Year(s) Of Engagement Activity | 2018 |
| URL | http://www.bbc.co.uk/news/uk-wales-43084710 |
| Description | UDBN website |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Primary Audience | Participants in your research and patient groups |
| Results and Impact | Website with open access and access restricted to registered users deemed to be bona fide researchers by UDBN. Restricted access permits search of phenotype data with results in summary form only. UDBN has distributed 80,000 DNA samples for numerous studies in part through use of the website. |
| Year(s) Of Engagement Activity | 2006,2007,2008,2009 |